| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |